Alcon Inc. (ALC)
90.55
0.94 (1.05%)
At close: Apr 14, 2025, 12:33 PM
1.05% (1D)
| Bid | 90.42 |
| Market Cap | 44.78B |
| Revenue (ttm) | 9.93B |
| Net Income (ttm) | 1.02B |
| EPS (ttm) | 2.05 |
| PE Ratio (ttm) | 44.17 |
| Forward PE | 27.29 |
| Analyst | Buy |
| Ask | 90.59 |
| Volume | 683,222 |
| Avg. Volume (20D) | 1,694,200 |
| Open | 89.61 |
| Previous Close | 89.61 |
| Day's Range | 89.26 - 91.47 |
| 52-Week Range | 77.54 - 101.10 |
| Beta | 0.77 |
About ALC
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical pr...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Apr 9, 2019
Employees 25,599
Stock Exchange NYSE
Ticker Symbol ALC
Website https://www.alcon.com
Analyst Forecast
According to 12 analyst ratings, the average rating for ALC stock is "Buy." The 12-month stock price forecast is $107, which is an increase of 18.17% from the latest price.
Stock ForecastsNext Earnings Release
Alcon Inc. is scheduled to release its earnings on May 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+6%
Alcon shares are trading higher. The company acqui...
Unlock content with
Pro Subscription
1 month ago
+2.41%
Alcon shares are trading higher after the company reported better-than-expected Q4 financial results.
